Molecular Profile | BRAF V600E BRAF T529N |
Therapy | PLX4720 |
Indication/Tumor Type | Advanced Solid Tumor |
Response Type | resistant |
Create By | c-seddy |
Update By | c-seddy |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References | BRAF V600E BRAF T529N | Advanced Solid Tumor | resistant | PLX4720 | Preclinical | Actionable | In a preclinical study, transformed cells expressing BRAF V600E and the gatepkeeper mutation BRAF T529N were insensitive to PLX4720 in culture (PMID: 20538618). | 20538618 |
---|
PubMed Id | Reference Title | Details |
---|---|---|
(20538618) | Gatekeeper mutations mediate resistance to BRAF-targeted therapies. | Full reference... |